ArticleFrontiers in oncology2022

A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED).

Thiru Prasanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.